LEAD - ANVISA Registration 82444370036
Access comprehensive regulatory information for LEAD in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370036 and manufactured by MAGELLAN DIAGNOSTICS, INC.. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including MAGELLAN DIAGNOSTICS, INC., BEIJING DIAGREAT BIOTECHNOLOGIES CO., LTD., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
82444370036
25351364462202217
07214566000165
Company Information
Dates and Status
Oct 27, 2022
VIGENTE
09/18/2025 19:00:01
AMMONIA
AMMONIA TEST KIT II
ARKRAY FACTORY INC
80430080019
Jul 10, 2023
Cadmium
Cadmium Determination Kit
BEIJING DIAGREAT BIOTECHNOLOGIES CO., LTD.
81086830064
May 22, 2023
DRUGS OF ABUSE PANEL
SureStep Multi-Drug One Step Multi-Line Screen Test Panel with Integrated E-Z Split Key Cup II (Urine)
INNOVACON, INC.
10071770905
Jul 27, 2020
LACTATE
Lactic Acid2 Reagent Kit
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502376
Feb 06, 2023
DRUGS OF ABUSE PANEL
Multi-Drug 10 One Step Multi-Line Screen Test Panel with Integrated E-Z Split Key Cup 3 A (Urine)
ABON BIOPHARM CO., LTD.
10071770805
Mar 30, 2015